Hiroyasu Sakai

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells

Masahito Shimizu, Yohei Shirakami, Hiroyasu Sakai et al. · Cancer Letters · 2008 · 129 citations

Hepatology, Tumor Microenvironment, Insulin-like Growth Factor +9

(−)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells

Masahito Shimizu, Yohei Shirakami, Hiroyasu Sakai et al. · Chemico-Biological Interactions · 2010 · 124 citations

Gallate Inhibits Growth, Oncology, Chemoprevention Strategy +10

(−)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-<i>db/db</i> Mice

Masahito Shimizu, Yohei Shirakami, Hiroyasu Sakai et al. · Cancer Prevention Research · 2008 · 104 citations · Full text

(–)‐Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor–vascular endothelial growth factor receptor axis

Yohei Shirakami, Masahito Shimizu, Seiji Adachi et al. · Cancer Science · 2009 · 101 citations · Full text

Chemoprevention Strategy, Pathology, Tumor Biology +17

Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands

Tamotsu Kiyoshima, Kaori Shima, Ieyoshi Kobayashi et al. · Oral Oncology · 2001 · 88 citations

Tumor Biology, Mucoepidermoid Carcinomas, Pathology +6